Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 941
Gene Symbol: CD80
CD80 		0.300 Biomarker disease CTD_human Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. 21399635 2011
Entrez Id: 3575
Gene Symbol: IL7R
IL7R 		0.300 Biomarker disease CTD_human Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. 21399635 2011
Entrez Id: 213
Gene Symbol: ALB
ALB 		0.300 Biomarker disease CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 4015
Gene Symbol: LOX
LOX 		0.300 Biomarker disease CTD_human Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2. 16023247 2005
Entrez Id: 915
Gene Symbol: CD3D
CD3D 		0.300 Biomarker disease CTD_human Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. 18422935 2008
Entrez Id: 10537
Gene Symbol: UBD
UBD 		0.300 Biomarker disease CTD_human Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. 18422935 2008
Entrez Id: 1003
Gene Symbol: CDH5
CDH5 		0.300 Biomarker disease CTD_human Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. 18422935 2008
Entrez Id: 4790
Gene Symbol: NFKB1
NFKB1 		0.300 Biomarker disease CTD_human Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. 21399635 2011
Entrez Id: 114757
Gene Symbol: CYGB
CYGB 		0.300 Biomarker disease CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 4017
Gene Symbol: LOXL2
LOXL2 		0.300 Biomarker disease CTD_human Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2. 16023247 2005
Entrez Id: 123264
Gene Symbol: SLC51B
SLC51B 		0.300 Biomarker disease CTD_human Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents. 16423920 2006
Entrez Id: 3484
Gene Symbol: IGFBP1
IGFBP1 		0.300 Biomarker disease CTD_human Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. 18422935 2008
Entrez Id: 3855
Gene Symbol: KRT7
KRT7 		0.300 Biomarker disease CTD_human Expression of cytokeratin 7 as a histological marker of cholestasis and stages of primary biliary cirrhosis. 21681009 2011
Entrez Id: 4846
Gene Symbol: NOS3
NOS3 		0.300 Biomarker disease CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 6522
Gene Symbol: SLC4A2
SLC4A2 		0.300 Biomarker disease CTD_human Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells. 18188457 2008
Entrez Id: 200931
Gene Symbol: SLC51A
SLC51A 		0.300 Biomarker disease CTD_human Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents. 16423920 2006
Entrez Id: 10412
Gene Symbol: NSA2
NSA2 		0.300 Biomarker disease CTD_human Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. 18422935 2008
Entrez Id: 6352
Gene Symbol: CCL5
CCL5 		0.300 Biomarker disease CTD_human Fibrates suppress chenodeoxycholic acid-induced RANTES expression through inhibition of NF-kappaB activation. 12126966 2002
Entrez Id: 7297
Gene Symbol: TYK2
TYK2 		0.300 Biomarker disease CTD_human Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. 22961000 2012
Entrez Id: 9817
Gene Symbol: KEAP1
KEAP1 		0.300 Biomarker disease CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2 		0.300 Biomarker disease CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 5970
Gene Symbol: RELA
RELA 		0.300 Biomarker disease CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 3593
Gene Symbol: IL12B
IL12B 		0.300 Biomarker disease CTD_human Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. 20639880 2010
Entrez Id: 3091
Gene Symbol: HIF1A
HIF1A 		0.300 Biomarker disease CTD_human Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice. 22271822 2012
Entrez Id: 6689
Gene Symbol: SPIB
SPIB 		0.400 GeneticVariation disease GWASCAT Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. 20639880 2010